期刊文献+

TNF-α诱导Molt-4细胞Bcl-2蛋白磷酸化的周期特异性 被引量:2

TNF-α Induces Apoptosis of Molt-4 Cells and Cell Cycle Specificity of Bcl-2 Phosphorylation
下载PDF
导出
摘要 目的以肿瘤坏死因子-α诱导的Molt-4细胞凋亡为模式,观察Bcl-2蛋白磷酸化有无细胞周期特异性,探讨膜受体途径介导的细胞凋亡的周期特异性发生机制。方法TNF-α诱导Molt-4细胞凋亡,API法检测细胞凋亡的细胞周期特异性。流式细胞仪分选各个细胞周期时相的细胞群,蛋白免疫印迹检测Bcl-2蛋白的细胞周期特异性表达。结果TNF-α诱导Molt-4细胞凋亡主要发生在细胞周期的G1期。Bcl-2蛋白在TNF-α诱导后表达增加,G1期Molt-4细胞中bcl-2部分磷酸化,在时间上与凋亡发生的时间一致。结论加入TNF-α培养的Molt-4细胞Bcl-2蛋白磷酸化失活与细胞凋亡的细胞周期时相一致,具有细胞周期特异性。 Objective To observe the expression of Bcl 2 and its phosphorylation in Molt-4 cells induced by tumor necrosis factor-α (TNF-α),and to investigate the possible mechanism of cell cycle specificity of apoptosis. Methods Exponentially growing Molt-4 cells were treated with TNF-α. Apoptosis was detected by DNA fragmentation assay. API Method was applied to illustrate the cell cycle specificity of apoptotic cells. Cells of sub-phases were sorted by FACSvantage flow cytometer and then submitted to immunoblot. Results Molt-4 cells which were treated with TNF-α went to apoptosis and showed a DNA ladder pattern. Most apoptosis happened in G1-phase of cell cycle. Bcl-2 expression increased for the Molt-4 cells treated with TNF-α. The phosphorylation state of Bcl-2 was only presented in G1-phase cells, in accordance with the specified time and cell cycle phase of apoptosis. Conclusion The phosphorylation of Bcl-2 in the Molt-4 cells treated with TNF-α happened with the same cell cycle specificity as cell apoptosis. The cell cycle specificity of Bcl-2 phosphoryaltion was one of the mechanisms of receptor-mediated apoptosis. The cell cycle machine can trigger the apoptosis program.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第3期251-254,共4页 Cancer Research on Prevention and Treatment
基金 卫生部临床重点学科资助项目(20012537) 科技部"973"肿瘤计划资助项目(2004CB518705)
关键词 细胞凋亡 BCL-2 磷酸化 细胞周期 Apoptosis Bcl-2 Phosphorylation Cell cycle
  • 相关文献

参考文献13

  • 1Sherr CJ. Cancer cell cycles [J]. Science, 1996, 274 (5293) : 1672-1677.
  • 2Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer[J]. Nature, 2001,411 (6835) : 342-348.
  • 3Attains JM, Cory S. The Bcl 2 protein family: arbiters of cell survival[J]. Science, 1998,281 (5381):1322-1326.
  • 4Tao D,Wu J,Feng Yet al. New method for the analysis of cell cycle-specific apoptosis[J]. Cytometry, 2004,57 (2) : 70-74.
  • 5King KL, Cidlowski JA. Cell cycle regulation and apoptosis[J]. Annu Rev Physiol, 1998,60 (1146) :601-617.
  • 6Mitchell SA, Randers-pehrson G, Brenner DJ, et al. The bystander response in C3H 10T 1/2 CELLS.. the influence of cell- to-cell contact[J]. Radiat Res,2004,161 (4) :397-401.
  • 7魏红梅,郭坤元,梅家转,常红,宋朝阳,邓兰,牛新青.热疗联合足叶乙甙对K562体外抑制效应及bcl-2的表达[J].肿瘤防治研究,2007,34(4):293-296. 被引量:4
  • 8Liang Y, Yan C, Nylander KD, et al. Early events in Bcl-2-enhanced apoptosis[J]. Apoptosis, 2003,8 (6) : 609-616.
  • 9Riparbelli MG, Callaini G, Tripodi SA, et al. Localization of the Bcl-2 protein to the outer mitochondrial membrane by electron microscopy[J]. Exp Cell Res, 1995,221 (2) :363-369.
  • 10Rudner J,Jendrossek V, Belka C. New insights in the role of Bcl-2 and the endoplasmic reticulum[J]. Apoptosis, 2002, 7 (5):441- 447.

二级参考文献15

共引文献3

同被引文献12

  • 1何友兼,董秋美,李宇红.结肠癌全身辅助化疗的进展[J].癌症,2005,24(12):1546-1549. 被引量:13
  • 2Pannala R, Leirness JB, BamletWR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus[J]. Gastroenterology,2008,134 (4):981-987.
  • 3Mason KA, Milas L, Hunter NR, et al. Maximizing therapeutic gain with gemeitabine and fractionated radiation [J]. Int J Radiat Oncol Biol Phys, 1999,44 (5) : 1125-1135.
  • 4Pauwels B, Korst AE, Lardon F, et al. Combined Modality Therapy of Gemcitabine and Radiation[J]. Oncologist, 2005,10 (1):34-51.
  • 5沈瑜,糜福顺.肿瘤放射生物学[M].2版.北京:中国医药科技出版社,2009:295-298.
  • 6Fennell DA, Chacko A, Mutti L. BCL-2 family regulation by the 20S proteasome inhibitor bortezomib[J]. Oncogene, 2008, 27(9) :1189-1197.
  • 7Rtibe CE,Wilfert F,Uthe D,et al. Increased expression of proinflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation[J].Radiother Oncol, 2004,72 (2) : 231-241.
  • 8Zinner RG, Komaki R, Cox JD, et al. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer[J] . Int J Radiat Oncol Biol Phys,2009,73(1) : 119-127.
  • 9伍小平,曹建国,孙丽.罗格列酮具有人结肠癌氟尿嘧啶化疗增敏作用[J].海南医学,2008,19(3):22-23. 被引量:2
  • 10Wenshan He,Tao Huang,Jinghua Ren,Jinghui Zhang.The effect of erythropoietin to the proliferation of cancer cell lines[J].The Chinese-German Journal of Clinical Oncology,2008,7(6):361-364. 被引量:3

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部